Magnetic nanoparticles for drug delivery
β Scribed by Jon Dobson
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 130 KB
- Volume
- 67
- Category
- Article
- ISSN
- 0272-4391
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Targeting specific sites in vivo for the delivery of therapeutic compounds presents a major obstacle to the treatment of many diseases. One targeted delivery technique that has gained prominence in recent years is the use of magnetic nanoparticles. In these systems, therapeutic compounds are attached to biocompatible magnetic nanoparticles and magnetic fields generated outside the body are focused on specific targets in vivo. The fields capture the particle complex resulting in enhanced delivery to the target site. This review will focus on technical aspects of magnetic targeting as well as nanoparticle design and animal and clinical trials. Drug Dev. Res. 67:55β60, 2006. Β© 2006 WileyβLiss, Inc.
π SIMILAR VOLUMES
## Core-shell mesoporous silica nanoparticles β¦ β¦ which consist of a single magnetite nanocrystal core and a dye-doped mesoporous silica shell, are presented by T. Hyeon, W. K. Moon and co-workers in their Communication on page 8438 ff. These multifunctional nanoparticles can be used in simultaneou
## Abstract Particulate drug delivery systems have become important in experimental pharmaceutics and clinical medicine. The distinction is often made between microβ and nanoparticles, being particles with dimensions best described in micrometers and nanometers respectively. That size difference en